Publication Information (EuropePMC) | |
Title | Prediction of venous thromboembolism incidence in the general adult population using two published genetic risk scores. |
PubMed ID | 36716319(Europe PMC) |
doi | 10.1371/journal.pone.0280657 |
Publication Date | Jan. 30, 2023 |
Journal | PLoS One |
Author(s) | Folsom AR, Tang W, Hong CP, Rosamond WD, Lane JA, Cushman M, Pankratz N. |
Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
---|---|---|---|---|---|---|
PGS003456 (PRS273_VTE) |
PGP000449 | Folsom AR et al. PLoS One (2023) |
Venous thromboembolism | venous thromboembolism | 273 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS003456/ScoringFiles/PGS003456.txt.gz |
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|---|
PPM017257 | PGS003456 (PRS273_VTE) |
PSS010177| African Ancestry| 2,484 individuals |
PGP000449 | Folsom AR et al. PLoS One (2023) |
Reported Trait: Total venous thromboembolism | — | — | Hazard ratio (HR, high vs low tertile): 1.35 [0.81, 2.25] | Adjusted for age, sex, principal components of ancestry, hormone replacement therapy (current, former, never for women, with men as referent category), education level (<high school, high school grad, >high school grad), household income (<$12,000, $12,000 to $24,999, $25,000 to $49,999, $50,000+, missing), height (continuous), weight (continuous), estimated glomerular filtration rate (continuous), diabetes (yes defined as >126 mg/dL, medication or physician diagnosis; no), smoking status (current, former, never), sports physical activity level (continuous), systolic blood pressure (continuous), antihypertensive medication use (yes, no) | — |
PPM017256 | PGS003456 (PRS273_VTE) |
PSS010178| European Ancestry| 8,808 individuals |
PGP000449 | Folsom AR et al. PLoS One (2023) |
Reported Trait: Total venous thromboembolism | — | — | Hazard ratio (HR, high vs low tertile): 2.52 [1.99, 3.2] | Adjusted for age, sex, principal components of ancestry, hormone replacement therapy (current, former, never for women, with men as referent category), education level (<high school, high school grad, >high school grad), household income (<$12,000, $12,000 to $24,999, $25,000 to $49,999, $50,000+, missing), height (continuous), weight (continuous), estimated glomerular filtration rate (continuous), diabetes (yes defined as >126 mg/dL, medication or physician diagnosis; no), smoking status (current, former, never), sports physical activity level (continuous), systolic blood pressure (continuous), antihypertensive medication use (yes, no) | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS010178 | — | Median = 28.0 years | 8,808 individuals | — | European | — | ARIC | — |
PSS010177 | — | Median = 28.0 years | 2,484 individuals | — | African unspecified | — | ARIC | — |